# Clinical Utility of Contrast-Enhanced Ultrasound (CEUS) in Urology: A Multisystem Review

**Authors:** Haadia Safdar, Mecaelan Sardar, Niharika Tekchandani, Ahsan Iftikhar, Haider Iftikhar, Faisal Ghumman, Javed Burki

PMC · DOI: 10.7759/cureus.94690 · Cureus · 2025-10-15

## TL;DR

This paper reviews how contrast-enhanced ultrasound is being used in urology for various diagnostic purposes, highlighting its benefits and current limitations.

## Contribution

The paper provides an updated overview of CEUS applications in urology and discusses barriers to its widespread adoption.

## Key findings

- CEUS is useful for renal mass characterization and bladder cancer staging.
- It supports diagnostic procedures like M-TESE and prostate cancer imaging.
- Standardized protocols and increased availability are needed for broader use.

## Abstract

Contrast-enhanced ultrasound (CEUS) is a non-invasive, versatile imaging technique with an expanding spectrum of uses across a wide variety of urological disorders. By utilizing microbubble-based contrast agents confined to the intravascular space, CEUS provides real-time, high-resolution assessment of tissue vascularity without ionizing radiation or nephrotoxic contrast. This review presents an updated overview of CEUS applications in urology, including renal mass characterization, staging of bladder cancer, assessment of scrotal trauma, fertility interventions such as microdissection testicular sperm extraction (M-TESE), and adjunctive prostate cancer imaging. Despite multiple advantages, the more widespread use of CEUS is limited by its limited availability and the absence of standardized imaging protocols. As evidence becomes increasingly available and consensus guidelines emerge, CEUS will take its place as a fundamental tool in the diagnostic armamentarium of modern urological practice.

## Linked entities

- **Diseases:** urological disorders (MONDO:0002118), bladder cancer (MONDO:0004986), prostate cancer (MONDO:0005159)

## Full-text entities

- **Diseases:** trauma (MESH:D014947), renal mass (MESH:C536030), urological disorders (MESH:D014570), prostate cancer (MESH:D011471), bladder cancer (MESH:D001749)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12618943/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12618943/full.md

---
Source: https://tomesphere.com/paper/PMC12618943